Medical Health & Life Science Research News

Companion diagnostics market research for 2017 available in new report

The assay kits & reagents segment accounted the largest share in 2016 and is expected to register the highest CAGR On forecast period. large share can attributed to its wide range of applications in platforms such as PCR, NGS, IHC, and ISH.

- Agency -.

Global companion diagnostics market projected to grow at CAGR of 20.1% 

The global Companion Diagnostics Market is projected to reach USD 6.51 billion by 2022 from USD 2.61 billion in 2017, at a CAGR of 20.1%. 

North America held the largest share of the global companion diagnostics market in 2016, while Asia-Pacific is expected to witness the highest growth during 2017 to 2022. Growing need for tailored therapeutics by the elderly population, increasing number of hospitals and diagnostic laboratories, and growing prevalence of life-threatening diseases are driving the growth of the companion diagnostics market in the Asia-Pacific region.

Get Sample Copy [email protected] www.reportsnreports.com/contacts/r…aspx?name=297416

Pharmaceutical and biopharmaceutical companies segment accounted for the largest share of the market in 2016. This end-user segment is also expected to register the highest CAGR during the forecast period.

- Agency -.

The large share and growth of this market can be attributed to increasing and significant application of companion diagnostics in the drug development process.

Target Audience:

  • Pharmaceutical and biotechnology companies
  • Diagnostic manufacturers
  • Research laboratories and academic institutes
  • Research and development (R&D) companies
  • Clinical research organizations (CROs) 

*Top 25 Companies Analysed for This Study are - Some of the major market players in the companion diagnostics market are F. Hoffmann-La Roche AG (Switzerland), Agilent Technologies, Inc.

(U.S.), and QIAGEN N.V. (Netherlands) dominated the global companion diagnostics market. Some of the other players competing in this market are Thermo Fisher Scientific Inc. (U.S.), Abbott Laboratories, Inc. (U.S.), Myriad Genetics, Inc. (U.S.), Danaher Corporation (U.S.), Almac Group (U.S.), and Sysmex Corporation (Japan). 

Access Companion diagnostics Market 2017-2022 Spreads Across 170 Pages Profiling 25+ Companies and Supported with 105 Tables And 37 Figures Available at www.reportsnreports.com/contacts/d…aspx?name=297416

Key Point from Table of Content 

Companion Diagnostics Market, By Product & Service
Introduction
Assay Kits and Reagents
Software & Services 

Companion Diagnostics Market, By Technology
Introduction
Polymerase Chain Reaction
Immunohistochemistry
In Situ Hybridization

Companion Diagnostics Market, By Indication
Introduction
Oncology
Breast Cancer
Lung Cancer
Colorectal Cancer

News From

ReportsnReports - Industry Trends & ForecastsReportsnReports
Category: Market Research Publishers and RetailersCompany profile: ReportsnReports.com provides market research reports to industries, individuals and organizations with an objective of helping them in their decision-making process. Our library of 400,000+ industry & country research reports covers 5000+ micro markets.